Staphylococcus aureus vaccine composition

The present invention relates to an immunogenic composition for inducing an immune response in a subject to treat and/or prevent Staphylococcus aureus infection. Immunogenic compositions disclosed herein comprise a Staphylococcus aureus protein A (SpA) polypeptide and a Staphylococcus aureus leukoci...

Full description

Saved in:
Bibliographic Details
Main Authors KONSTANTINOV SERGEY, TORRES VICTOR J, SOMANI SANJAY, LUO JINQUAN, POOLMAN JAN THEUNIS, GEURTSEN, JENS, BUCKLEY PAUL T, MOREAU BENOIT
Format Patent
LanguageChinese
English
Published 05.01.2024
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an immunogenic composition for inducing an immune response in a subject to treat and/or prevent Staphylococcus aureus infection. Immunogenic compositions disclosed herein comprise a Staphylococcus aureus protein A (SpA) polypeptide and a Staphylococcus aureus leukocidin A (LukA) and/or leukocidin B (LukB) variant polypeptide. The invention also relates to methods of generating an immune response against Staphylococcus aureus in a subject involving administering the disclosed immunogenic compositions. 本发明涉及用于诱导对象免疫应答以治疗和/或预防金黄色葡萄球菌感染的免疫原性组合物。本文公开的免疫原性组合物包含金黄色葡萄球菌蛋白A(SpA)多肽和金黄色葡萄球菌杀白细胞素A(LukA)和/或杀白细胞素B(LukB)变体多肽。本发明还涉及在对象中产生针对金黄色葡萄球菌的免疫应答的方法,其涉及施用所公开的免疫原性组合物。
Bibliography:Application Number: CN202280034397